nodes	percent_of_prediction	percent_of_DWPC	metapath
Lisinopril—Nateglinide—type 2 diabetes mellitus	0.172	0.622	CrCtD
Lisinopril—coronary artery disease—type 2 diabetes mellitus	0.134	0.627	CtDrD
Lisinopril—Ramipril—type 2 diabetes mellitus	0.104	0.378	CrCtD
Lisinopril—ACE—type 2 diabetes mellitus	0.0896	1	CbGaD
Lisinopril—hypertension—type 2 diabetes mellitus	0.0801	0.374	CtDrD
Lisinopril—ACE—Ramipril—type 2 diabetes mellitus	0.036	0.234	CbGbCtD
Lisinopril—ACE—Losartan—type 2 diabetes mellitus	0.0212	0.138	CbGbCtD
Lisinopril—SLC15A1—Chlorpropamide—type 2 diabetes mellitus	0.0182	0.118	CbGbCtD
Lisinopril—SLC15A1—Tolbutamide—type 2 diabetes mellitus	0.0162	0.105	CbGbCtD
Lisinopril—Spirapril—Nateglinide—type 2 diabetes mellitus	0.0152	0.0866	CrCrCtD
Lisinopril—Cilazapril—Nateglinide—type 2 diabetes mellitus	0.0152	0.0866	CrCrCtD
Lisinopril—SLC15A1—Ramipril—type 2 diabetes mellitus	0.0144	0.0937	CbGbCtD
Lisinopril—Ramipril—Nateglinide—type 2 diabetes mellitus	0.0143	0.0813	CrCrCtD
Lisinopril—Trandolapril—Nateglinide—type 2 diabetes mellitus	0.0143	0.0813	CrCrCtD
Lisinopril—Enalapril—Nateglinide—type 2 diabetes mellitus	0.0143	0.0813	CrCrCtD
Lisinopril—Fosinopril—Ramipril—type 2 diabetes mellitus	0.0142	0.0811	CrCrCtD
Lisinopril—SLC15A1—Nateglinide—type 2 diabetes mellitus	0.0138	0.0894	CbGbCtD
Lisinopril—Aspartame—Nateglinide—type 2 diabetes mellitus	0.0121	0.0688	CrCrCtD
Lisinopril—Moexipril—Ramipril—type 2 diabetes mellitus	0.0107	0.061	CrCrCtD
Lisinopril—SLC15A1—Glyburide—type 2 diabetes mellitus	0.0093	0.0604	CbGbCtD
Lisinopril—Cilazapril—Ramipril—type 2 diabetes mellitus	0.00925	0.0527	CrCrCtD
Lisinopril—Spirapril—Ramipril—type 2 diabetes mellitus	0.00925	0.0527	CrCrCtD
Lisinopril—Trandolapril—Ramipril—type 2 diabetes mellitus	0.00868	0.0494	CrCrCtD
Lisinopril—Enalapril—Ramipril—type 2 diabetes mellitus	0.00868	0.0494	CrCrCtD
Lisinopril—Nateglinide—Ramipril—type 2 diabetes mellitus	0.00774	0.0441	CrCrCtD
Lisinopril—Quinapril—Ramipril—type 2 diabetes mellitus	0.00735	0.0419	CrCrCtD
Lisinopril—Aspartame—Ramipril—type 2 diabetes mellitus	0.00735	0.0419	CrCrCtD
Lisinopril—Benazepril—Ramipril—type 2 diabetes mellitus	0.007	0.0399	CrCrCtD
Lisinopril—ABCB1—Linagliptin—type 2 diabetes mellitus	0.00692	0.0449	CbGbCtD
Lisinopril—ABCB1—Sitagliptin—type 2 diabetes mellitus	0.00617	0.04	CbGbCtD
Lisinopril—ABCB1—Chlorpropamide—type 2 diabetes mellitus	0.00446	0.029	CbGbCtD
Lisinopril—ABCB1—Bromocriptine—type 2 diabetes mellitus	0.00306	0.0199	CbGbCtD
Lisinopril—ACE—arteriole—type 2 diabetes mellitus	0.00233	0.133	CbGeAlD
Lisinopril—ABCB1—Glyburide—type 2 diabetes mellitus	0.00228	0.0148	CbGbCtD
Lisinopril—ABCB1—Losartan—type 2 diabetes mellitus	0.00209	0.0136	CbGbCtD
Lisinopril—ACE—forelimb zeugopod—type 2 diabetes mellitus	0.00204	0.116	CbGeAlD
Lisinopril—ACE—tunica intima—type 2 diabetes mellitus	0.00165	0.0942	CbGeAlD
Lisinopril—ACE—sympathetic nervous system—type 2 diabetes mellitus	0.00148	0.0846	CbGeAlD
Lisinopril—ACE—autonomic nervous system—type 2 diabetes mellitus	0.000997	0.0569	CbGeAlD
Lisinopril—ACE—hindlimb—type 2 diabetes mellitus	0.000922	0.0526	CbGeAlD
Lisinopril—ACE—peripheral nervous system—type 2 diabetes mellitus	0.000719	0.041	CbGeAlD
Lisinopril—ACE2—nephron tubule—type 2 diabetes mellitus	0.000669	0.0382	CbGeAlD
Lisinopril—ACE2—cardiovascular system—type 2 diabetes mellitus	0.000601	0.0343	CbGeAlD
Lisinopril—ACE2—kidney—type 2 diabetes mellitus	0.000588	0.0335	CbGeAlD
Lisinopril—ACE2—cortex of kidney—type 2 diabetes mellitus	0.000573	0.0327	CbGeAlD
Lisinopril—ACE—artery—type 2 diabetes mellitus	0.000565	0.0322	CbGeAlD
Lisinopril—ACE—nerve—type 2 diabetes mellitus	0.000561	0.032	CbGeAlD
Lisinopril—ACE2—adipose tissue—type 2 diabetes mellitus	0.00053	0.0302	CbGeAlD
Lisinopril—ACE—endothelium—type 2 diabetes mellitus	0.000477	0.0272	CbGeAlD
Lisinopril—ACE2—liver—type 2 diabetes mellitus	0.000372	0.0212	CbGeAlD
Lisinopril—SLC15A1—nephron tubule—type 2 diabetes mellitus	0.000305	0.0174	CbGeAlD
Lisinopril—SLC15A1—kidney—type 2 diabetes mellitus	0.000268	0.0153	CbGeAlD
Lisinopril—ACE—nephron tubule—type 2 diabetes mellitus	0.000219	0.0125	CbGeAlD
Lisinopril—ACE—cardiovascular system—type 2 diabetes mellitus	0.000196	0.0112	CbGeAlD
Lisinopril—ACE—kidney—type 2 diabetes mellitus	0.000192	0.011	CbGeAlD
Lisinopril—ACE—cortex of kidney—type 2 diabetes mellitus	0.000187	0.0107	CbGeAlD
Lisinopril—ACE—adipose tissue—type 2 diabetes mellitus	0.000173	0.00988	CbGeAlD
Lisinopril—SLC15A1—liver—type 2 diabetes mellitus	0.000169	0.00966	CbGeAlD
Lisinopril—ACE—liver—type 2 diabetes mellitus	0.000121	0.00693	CbGeAlD
Lisinopril—Nateglinide—ABCC8—type 2 diabetes mellitus	0.00011	0.101	CrCbGaD
Lisinopril—Fosinopril—ACE—type 2 diabetes mellitus	0.00011	0.1	CrCbGaD
Lisinopril—ABCB1—islet of Langerhans—type 2 diabetes mellitus	9.56e-05	0.00545	CbGeAlD
Lisinopril—Spirapril—ACE—type 2 diabetes mellitus	8.85e-05	0.0807	CrCbGaD
Lisinopril—Moexipril—ACE—type 2 diabetes mellitus	8.49e-05	0.0773	CrCbGaD
Lisinopril—Benazepril—MTHFR—type 2 diabetes mellitus	8.42e-05	0.0767	CrCbGaD
Lisinopril—ABCB1—retina—type 2 diabetes mellitus	8.18e-05	0.00466	CbGeAlD
Lisinopril—Quinapril—ACE—type 2 diabetes mellitus	7.89e-05	0.0719	CrCbGaD
Lisinopril—Cilazapril—ACE—type 2 diabetes mellitus	7.89e-05	0.0719	CrCbGaD
Lisinopril—Nateglinide—KCNJ11—type 2 diabetes mellitus	7.77e-05	0.0708	CrCbGaD
Lisinopril—ABCB1—nephron tubule—type 2 diabetes mellitus	7.7e-05	0.00439	CbGeAlD
Lisinopril—Trandolapril—ACE—type 2 diabetes mellitus	7.64e-05	0.0696	CrCbGaD
Lisinopril—Ramipril—ACE—type 2 diabetes mellitus	7.64e-05	0.0696	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	7.58e-05	0.00426	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—WFS1—type 2 diabetes mellitus	7.16e-05	0.00402	CbGpPWpGaD
Lisinopril—ABCB1—Drug Induction of Bile Acid Pathway—CYP3A4—type 2 diabetes mellitus	7.02e-05	0.00395	CbGpPWpGaD
Lisinopril—ABCB1—cardiovascular system—type 2 diabetes mellitus	6.92e-05	0.00394	CbGeAlD
Lisinopril—Benazepril—ACE—type 2 diabetes mellitus	6.86e-05	0.0625	CrCbGaD
Lisinopril—ABCB1—kidney—type 2 diabetes mellitus	6.77e-05	0.00386	CbGeAlD
Lisinopril—ABCB1—pancreas—type 2 diabetes mellitus	6.72e-05	0.00383	CbGeAlD
Lisinopril—ABCB1—cortex of kidney—type 2 diabetes mellitus	6.59e-05	0.00376	CbGeAlD
Lisinopril—ACE—Peptide hormone metabolism—AGT—type 2 diabetes mellitus	6.53e-05	0.00367	CbGpPWpGaD
Lisinopril—SLC15A1—Transport of inorganic cations/anions and amino acids/oligopeptides—SLC9A1—type 2 diabetes mellitus	6.47e-05	0.00364	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	6.46e-05	0.00363	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—LEP—type 2 diabetes mellitus	6.4e-05	0.0036	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	6.15e-05	0.00346	CbGpPWpGaD
Lisinopril—ABCB1—adipose tissue—type 2 diabetes mellitus	6.1e-05	0.00348	CbGeAlD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A4—type 2 diabetes mellitus	5.99e-05	0.00337	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—ABCC2—type 2 diabetes mellitus	5.88e-05	0.0033	CbGpPWpGaD
Lisinopril—Enalapril—ACE—type 2 diabetes mellitus	5.79e-05	0.0528	CrCbGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—G6PC—type 2 diabetes mellitus	5.79e-05	0.00325	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ATF3—type 2 diabetes mellitus	5.62e-05	0.00316	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—INS—type 2 diabetes mellitus	5.47e-05	0.00307	CbGpPWpGaD
Lisinopril—ACE—Peptide hormone metabolism—IGF1—type 2 diabetes mellitus	5.29e-05	0.00297	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—F7—type 2 diabetes mellitus	5.04e-05	0.00283	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—PAX6—type 2 diabetes mellitus	4.91e-05	0.00276	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC30A8—type 2 diabetes mellitus	4.72e-05	0.00265	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ADAMTS9—type 2 diabetes mellitus	4.61e-05	0.00259	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	4.56e-05	0.00256	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC5A2—type 2 diabetes mellitus	4.54e-05	0.00255	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—GHRL—type 2 diabetes mellitus	4.5e-05	0.00253	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—ACE—type 2 diabetes mellitus	4.35e-05	0.00245	CbGpPWpGaD
Lisinopril—Nateglinide—PPARG—type 2 diabetes mellitus	4.31e-05	0.0392	CrCbGaD
Lisinopril—ABCB1—liver—type 2 diabetes mellitus	4.28e-05	0.00244	CbGeAlD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—CYP3A4—type 2 diabetes mellitus	4.23e-05	0.00238	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	4.18e-05	0.00235	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	4.18e-05	0.00235	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	4.14e-05	0.00232	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—GCG—type 2 diabetes mellitus	4.11e-05	0.00231	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—type 2 diabetes mellitus	4.03e-05	0.00227	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HK1—type 2 diabetes mellitus	3.91e-05	0.0022	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—HK1—type 2 diabetes mellitus	3.86e-05	0.00217	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—SLC30A8—type 2 diabetes mellitus	3.76e-05	0.00211	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—DPP4—type 2 diabetes mellitus	3.76e-05	0.00211	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—GCKR—type 2 diabetes mellitus	3.73e-05	0.0021	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—GIP—type 2 diabetes mellitus	3.62e-05	0.00203	CbGpPWpGaD
Lisinopril—ABCB1—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	3.59e-05	0.00202	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—GNB3—type 2 diabetes mellitus	3.54e-05	0.00199	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PCSK1—type 2 diabetes mellitus	3.5e-05	0.00197	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—IGF2—type 2 diabetes mellitus	3.48e-05	0.00196	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ST6GAL1—type 2 diabetes mellitus	3.39e-05	0.0019	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A2—type 2 diabetes mellitus	3.1e-05	0.00174	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HNF4A—type 2 diabetes mellitus	3.08e-05	0.00173	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	3.04e-05	0.00171	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—GCK—type 2 diabetes mellitus	3e-05	0.00169	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—GCK—type 2 diabetes mellitus	2.96e-05	0.00166	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	2.94e-05	0.00165	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	2.94e-05	0.00165	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC9A1—type 2 diabetes mellitus	2.89e-05	0.00162	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—MMP1—type 2 diabetes mellitus	2.79e-05	0.00157	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—AGT—type 2 diabetes mellitus	2.76e-05	0.00155	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	2.75e-05	0.00154	CbGpPWpGaD
Lisinopril—Enalapril—CYP3A4—type 2 diabetes mellitus	2.72e-05	0.0248	CrCbGaD
Lisinopril—ACE2—Metabolism of proteins—LEP—type 2 diabetes mellitus	2.7e-05	0.00152	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	2.69e-05	0.00151	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—ATF3—type 2 diabetes mellitus	2.51e-05	0.00141	CbGpPWpGaD
Lisinopril—ABCB1—ABC-family proteins mediated transport—APOA1—type 2 diabetes mellitus	2.46e-05	0.00138	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SLC2A1—type 2 diabetes mellitus	2.43e-05	0.00137	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A1—type 2 diabetes mellitus	2.4e-05	0.00135	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	2.4e-05	0.00135	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	2.4e-05	0.00135	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—INS—type 2 diabetes mellitus	2.31e-05	0.0013	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	2.31e-05	0.0013	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	2.31e-05	0.0013	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—SLC2A4—type 2 diabetes mellitus	2.3e-05	0.00129	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PLN—type 2 diabetes mellitus	2.29e-05	0.00129	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—CCL2—type 2 diabetes mellitus	2.27e-05	0.00128	CbGpPWpGaD
Lisinopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	2.27e-05	0.00128	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	2.27e-05	0.00127	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—F7—type 2 diabetes mellitus	2.25e-05	0.00127	CbGpPWpGaD
Lisinopril—ACE2—Metabolism of proteins—IGF1—type 2 diabetes mellitus	2.23e-05	0.00126	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—PAX6—type 2 diabetes mellitus	2.19e-05	0.00123	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	2.1e-05	0.00118	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—GHRL—type 2 diabetes mellitus	2.01e-05	0.00113	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HMOX1—type 2 diabetes mellitus	2e-05	0.00112	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	1.96e-05	0.0011	CbGpPWpGaD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—AVP—type 2 diabetes mellitus	1.96e-05	0.0011	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	1.89e-05	0.00106	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—EDN1—type 2 diabetes mellitus	1.89e-05	0.00106	CbGpPWpGaD
Lisinopril—ACE—Metabolism of proteins—TCF7L2—type 2 diabetes mellitus	1.87e-05	0.00105	CbGpPWpGaD
Lisinopril—Nateglinide—CYP3A4—type 2 diabetes mellitus	1.86e-05	0.0169	CrCbGaD
Lisinopril—ACE—Metabolism of proteins—GCG—type 2 diabetes mellitus	1.84e-05	0.00103	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	1.82e-05	0.00102	CbGpPWpGaD
Lisinopril—Shock—Metformin—type 2 diabetes mellitus	1.67e-05	0.00031	CcSEcCtD
Lisinopril—Insomnia—Orlistat—type 2 diabetes mellitus	1.67e-05	0.000309	CcSEcCtD
Lisinopril—Malaise—Losartan—type 2 diabetes mellitus	1.67e-05	0.000309	CcSEcCtD
Lisinopril—Anxiety—Irbesartan—type 2 diabetes mellitus	1.67e-05	0.000309	CcSEcCtD
Lisinopril—Hypersensitivity—Glyburide—type 2 diabetes mellitus	1.67e-05	0.000309	CcSEcCtD
Lisinopril—Thrombocytopenia—Metformin—type 2 diabetes mellitus	1.66e-05	0.000309	CcSEcCtD
Lisinopril—Dyspnoea—Valsartan—type 2 diabetes mellitus	1.66e-05	0.000309	CcSEcCtD
Lisinopril—Vertigo—Losartan—type 2 diabetes mellitus	1.66e-05	0.000308	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	1.66e-05	0.000308	CcSEcCtD
Lisinopril—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	1.66e-05	0.000308	CcSEcCtD
Lisinopril—Somnolence—Valsartan—type 2 diabetes mellitus	1.66e-05	0.000308	CcSEcCtD
Lisinopril—Syncope—Losartan—type 2 diabetes mellitus	1.66e-05	0.000308	CcSEcCtD
Lisinopril—Paraesthesia—Orlistat—type 2 diabetes mellitus	1.65e-05	0.000307	CcSEcCtD
Lisinopril—Leukopenia—Losartan—type 2 diabetes mellitus	1.65e-05	0.000307	CcSEcCtD
Lisinopril—Discomfort—Irbesartan—type 2 diabetes mellitus	1.65e-05	0.000307	CcSEcCtD
Lisinopril—Skin disorder—Metformin—type 2 diabetes mellitus	1.65e-05	0.000306	CcSEcCtD
Lisinopril—Hyperhidrosis—Metformin—type 2 diabetes mellitus	1.64e-05	0.000305	CcSEcCtD
Lisinopril—Dyspepsia—Valsartan—type 2 diabetes mellitus	1.64e-05	0.000305	CcSEcCtD
Lisinopril—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	1.64e-05	0.000304	CcSEcCtD
Lisinopril—Dizziness—Bromocriptine—type 2 diabetes mellitus	1.64e-05	0.000303	CcSEcCtD
Lisinopril—Dry mouth—Irbesartan—type 2 diabetes mellitus	1.64e-05	0.000303	CcSEcCtD
Lisinopril—Palpitations—Losartan—type 2 diabetes mellitus	1.63e-05	0.000303	CcSEcCtD
Lisinopril—Nausea—Glimepiride—type 2 diabetes mellitus	1.63e-05	0.000302	CcSEcCtD
Lisinopril—Arrhythmia—Ramipril—type 2 diabetes mellitus	1.63e-05	0.000302	CcSEcCtD
Lisinopril—Loss of consciousness—Losartan—type 2 diabetes mellitus	1.62e-05	0.000301	CcSEcCtD
Lisinopril—Nausea—Sitagliptin—type 2 diabetes mellitus	1.62e-05	0.000301	CcSEcCtD
Lisinopril—Dyspepsia—Orlistat—type 2 diabetes mellitus	1.62e-05	0.000301	CcSEcCtD
Lisinopril—Asthenia—Glyburide—type 2 diabetes mellitus	1.62e-05	0.000301	CcSEcCtD
Lisinopril—Decreased appetite—Valsartan—type 2 diabetes mellitus	1.62e-05	0.000301	CcSEcCtD
Lisinopril—Nateglinide—ALB—type 2 diabetes mellitus	1.62e-05	0.0148	CrCbGaD
Lisinopril—Anorexia—Metformin—type 2 diabetes mellitus	1.62e-05	0.0003	CcSEcCtD
Lisinopril—Cough—Losartan—type 2 diabetes mellitus	1.61e-05	0.000299	CcSEcCtD
Lisinopril—Urticaria—Gliclazide—type 2 diabetes mellitus	1.61e-05	0.000299	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	1.61e-05	0.000299	CcSEcCtD
Lisinopril—Alopecia—Ramipril—type 2 diabetes mellitus	1.61e-05	0.000299	CcSEcCtD
Lisinopril—Fatigue—Valsartan—type 2 diabetes mellitus	1.61e-05	0.000298	CcSEcCtD
Lisinopril—Body temperature increased—Gliclazide—type 2 diabetes mellitus	1.6e-05	0.000298	CcSEcCtD
Lisinopril—Abdominal pain—Gliclazide—type 2 diabetes mellitus	1.6e-05	0.000298	CcSEcCtD
Lisinopril—Oedema—Irbesartan—type 2 diabetes mellitus	1.6e-05	0.000297	CcSEcCtD
Lisinopril—Anaphylactic shock—Irbesartan—type 2 diabetes mellitus	1.6e-05	0.000297	CcSEcCtD
Lisinopril—Decreased appetite—Orlistat—type 2 diabetes mellitus	1.6e-05	0.000297	CcSEcCtD
Lisinopril—Pruritus—Glyburide—type 2 diabetes mellitus	1.6e-05	0.000297	CcSEcCtD
Lisinopril—Mental disorder—Ramipril—type 2 diabetes mellitus	1.6e-05	0.000296	CcSEcCtD
Lisinopril—Constipation—Valsartan—type 2 diabetes mellitus	1.6e-05	0.000296	CcSEcCtD
Lisinopril—Infection—Irbesartan—type 2 diabetes mellitus	1.59e-05	0.000295	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	1.59e-05	0.000295	CcSEcCtD
Lisinopril—Fatigue—Orlistat—type 2 diabetes mellitus	1.59e-05	0.000295	CcSEcCtD
Lisinopril—Hypotension—Metformin—type 2 diabetes mellitus	1.59e-05	0.000295	CcSEcCtD
Lisinopril—Malnutrition—Ramipril—type 2 diabetes mellitus	1.58e-05	0.000294	CcSEcCtD
Lisinopril—Erythema—Ramipril—type 2 diabetes mellitus	1.58e-05	0.000294	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—GNB3—type 2 diabetes mellitus	1.58e-05	0.00089	CbGpPWpGaD
Lisinopril—Shock—Irbesartan—type 2 diabetes mellitus	1.58e-05	0.000293	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	1.58e-05	0.000886	CbGpPWpGaD
Lisinopril—Pain—Orlistat—type 2 diabetes mellitus	1.58e-05	0.000292	CcSEcCtD
Lisinopril—Arthralgia—Losartan—type 2 diabetes mellitus	1.57e-05	0.000292	CcSEcCtD
Lisinopril—Myalgia—Losartan—type 2 diabetes mellitus	1.57e-05	0.000292	CcSEcCtD
Lisinopril—Chest pain—Losartan—type 2 diabetes mellitus	1.57e-05	0.000292	CcSEcCtD
Lisinopril—Vomiting—Bromocriptine—type 2 diabetes mellitus	1.57e-05	0.000292	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—HIF1A—type 2 diabetes mellitus	1.57e-05	0.000883	CbGpPWpGaD
Lisinopril—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	1.57e-05	0.000291	CcSEcCtD
Lisinopril—Anxiety—Losartan—type 2 diabetes mellitus	1.57e-05	0.000291	CcSEcCtD
Lisinopril—Tachycardia—Irbesartan—type 2 diabetes mellitus	1.56e-05	0.00029	CcSEcCtD
Lisinopril—Rash—Bromocriptine—type 2 diabetes mellitus	1.56e-05	0.000289	CcSEcCtD
Lisinopril—Dermatitis—Bromocriptine—type 2 diabetes mellitus	1.56e-05	0.000289	CcSEcCtD
Lisinopril—Skin disorder—Irbesartan—type 2 diabetes mellitus	1.56e-05	0.000289	CcSEcCtD
Lisinopril—Tension—Ramipril—type 2 diabetes mellitus	1.56e-05	0.000289	CcSEcCtD
Lisinopril—Discomfort—Losartan—type 2 diabetes mellitus	1.55e-05	0.000288	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—IGF2—type 2 diabetes mellitus	1.55e-05	0.000874	CbGpPWpGaD
Lisinopril—Dysgeusia—Ramipril—type 2 diabetes mellitus	1.55e-05	0.000288	CcSEcCtD
Lisinopril—Hyperhidrosis—Irbesartan—type 2 diabetes mellitus	1.55e-05	0.000288	CcSEcCtD
Lisinopril—Headache—Bromocriptine—type 2 diabetes mellitus	1.55e-05	0.000287	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	1.55e-05	0.000287	CcSEcCtD
Lisinopril—Diarrhoea—Glyburide—type 2 diabetes mellitus	1.55e-05	0.000287	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	1.54e-05	0.000867	CbGpPWpGaD
Lisinopril—Nervousness—Ramipril—type 2 diabetes mellitus	1.54e-05	0.000286	CcSEcCtD
Lisinopril—Dry mouth—Losartan—type 2 diabetes mellitus	1.54e-05	0.000286	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—LEP—type 2 diabetes mellitus	1.53e-05	0.000862	CbGpPWpGaD
Lisinopril—Anorexia—Irbesartan—type 2 diabetes mellitus	1.53e-05	0.000284	CcSEcCtD
Lisinopril—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	1.53e-05	0.000283	CcSEcCtD
Lisinopril—Paraesthesia—Metformin—type 2 diabetes mellitus	1.53e-05	0.000283	CcSEcCtD
Lisinopril—Muscle spasms—Ramipril—type 2 diabetes mellitus	1.52e-05	0.000283	CcSEcCtD
Lisinopril—Confusional state—Losartan—type 2 diabetes mellitus	1.52e-05	0.000282	CcSEcCtD
Lisinopril—Feeling abnormal—Orlistat—type 2 diabetes mellitus	1.52e-05	0.000282	CcSEcCtD
Lisinopril—Dyspnoea—Metformin—type 2 diabetes mellitus	1.51e-05	0.000281	CcSEcCtD
Lisinopril—Somnolence—Metformin—type 2 diabetes mellitus	1.51e-05	0.00028	CcSEcCtD
Lisinopril—Oedema—Losartan—type 2 diabetes mellitus	1.51e-05	0.00028	CcSEcCtD
Lisinopril—Anaphylactic shock—Losartan—type 2 diabetes mellitus	1.51e-05	0.00028	CcSEcCtD
Lisinopril—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	1.51e-05	0.00028	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	1.51e-05	0.000846	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	1.51e-05	0.000846	CbGpPWpGaD
Lisinopril—Infection—Losartan—type 2 diabetes mellitus	1.5e-05	0.000278	CcSEcCtD
Lisinopril—Hypotension—Irbesartan—type 2 diabetes mellitus	1.5e-05	0.000278	CcSEcCtD
Lisinopril—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	1.5e-05	0.000278	CcSEcCtD
Lisinopril—Dyspepsia—Metformin—type 2 diabetes mellitus	1.5e-05	0.000277	CcSEcCtD
Lisinopril—Tremor—Ramipril—type 2 diabetes mellitus	1.48e-05	0.000276	CcSEcCtD
Lisinopril—Shock—Losartan—type 2 diabetes mellitus	1.48e-05	0.000275	CcSEcCtD
Lisinopril—Urticaria—Valsartan—type 2 diabetes mellitus	1.48e-05	0.000275	CcSEcCtD
Lisinopril—Thrombocytopenia—Losartan—type 2 diabetes mellitus	1.48e-05	0.000274	CcSEcCtD
Lisinopril—Decreased appetite—Metformin—type 2 diabetes mellitus	1.48e-05	0.000274	CcSEcCtD
Lisinopril—Abdominal pain—Valsartan—type 2 diabetes mellitus	1.47e-05	0.000274	CcSEcCtD
Lisinopril—Tachycardia—Losartan—type 2 diabetes mellitus	1.47e-05	0.000273	CcSEcCtD
Lisinopril—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	1.47e-05	0.000273	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	1.47e-05	0.000826	CbGpPWpGaD
Lisinopril—Nausea—Bromocriptine—type 2 diabetes mellitus	1.47e-05	0.000273	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	1.47e-05	0.000272	CcSEcCtD
Lisinopril—Fatigue—Metformin—type 2 diabetes mellitus	1.46e-05	0.000272	CcSEcCtD
Lisinopril—Urticaria—Orlistat—type 2 diabetes mellitus	1.46e-05	0.000272	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	1.46e-05	0.000821	CbGpPWpGaD
Lisinopril—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	1.46e-05	0.000271	CcSEcCtD
Lisinopril—Hyperhidrosis—Losartan—type 2 diabetes mellitus	1.46e-05	0.000271	CcSEcCtD
Lisinopril—Abdominal pain—Orlistat—type 2 diabetes mellitus	1.46e-05	0.00027	CcSEcCtD
Lisinopril—Body temperature increased—Orlistat—type 2 diabetes mellitus	1.46e-05	0.00027	CcSEcCtD
Lisinopril—Asthenia—Gliclazide—type 2 diabetes mellitus	1.46e-05	0.00027	CcSEcCtD
Lisinopril—Constipation—Metformin—type 2 diabetes mellitus	1.45e-05	0.00027	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	1.45e-05	0.000816	CbGpPWpGaD
Lisinopril—Angioedema—Ramipril—type 2 diabetes mellitus	1.45e-05	0.000269	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—FAS—type 2 diabetes mellitus	1.45e-05	0.000814	CbGpPWpGaD
Lisinopril—Paraesthesia—Irbesartan—type 2 diabetes mellitus	1.44e-05	0.000267	CcSEcCtD
Lisinopril—Anorexia—Losartan—type 2 diabetes mellitus	1.44e-05	0.000267	CcSEcCtD
Lisinopril—Vomiting—Glyburide—type 2 diabetes mellitus	1.44e-05	0.000267	CcSEcCtD
Lisinopril—Pruritus—Gliclazide—type 2 diabetes mellitus	1.44e-05	0.000267	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—NOS2—type 2 diabetes mellitus	1.43e-05	0.000803	CbGpPWpGaD
Lisinopril—Malaise—Ramipril—type 2 diabetes mellitus	1.43e-05	0.000265	CcSEcCtD
Lisinopril—Dyspnoea—Irbesartan—type 2 diabetes mellitus	1.43e-05	0.000265	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—C3—type 2 diabetes mellitus	1.43e-05	0.000802	CbGpPWpGaD
Lisinopril—Rash—Glyburide—type 2 diabetes mellitus	1.43e-05	0.000265	CcSEcCtD
Lisinopril—Somnolence—Irbesartan—type 2 diabetes mellitus	1.42e-05	0.000264	CcSEcCtD
Lisinopril—Dermatitis—Glyburide—type 2 diabetes mellitus	1.42e-05	0.000264	CcSEcCtD
Lisinopril—Vertigo—Ramipril—type 2 diabetes mellitus	1.42e-05	0.000264	CcSEcCtD
Lisinopril—Syncope—Ramipril—type 2 diabetes mellitus	1.42e-05	0.000264	CcSEcCtD
Lisinopril—Leukopenia—Ramipril—type 2 diabetes mellitus	1.42e-05	0.000263	CcSEcCtD
Lisinopril—Headache—Glyburide—type 2 diabetes mellitus	1.42e-05	0.000263	CcSEcCtD
Lisinopril—Dyspepsia—Irbesartan—type 2 diabetes mellitus	1.41e-05	0.000262	CcSEcCtD
Lisinopril—Hypotension—Losartan—type 2 diabetes mellitus	1.41e-05	0.000262	CcSEcCtD
Lisinopril—Palpitations—Ramipril—type 2 diabetes mellitus	1.4e-05	0.00026	CcSEcCtD
Lisinopril—Feeling abnormal—Metformin—type 2 diabetes mellitus	1.4e-05	0.00026	CcSEcCtD
Lisinopril—Decreased appetite—Irbesartan—type 2 diabetes mellitus	1.39e-05	0.000259	CcSEcCtD
Lisinopril—Loss of consciousness—Ramipril—type 2 diabetes mellitus	1.39e-05	0.000258	CcSEcCtD
Lisinopril—Diarrhoea—Gliclazide—type 2 diabetes mellitus	1.39e-05	0.000258	CcSEcCtD
Lisinopril—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	1.39e-05	0.000258	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	1.38e-05	0.000257	CcSEcCtD
Lisinopril—Cough—Ramipril—type 2 diabetes mellitus	1.38e-05	0.000257	CcSEcCtD
Lisinopril—Fatigue—Irbesartan—type 2 diabetes mellitus	1.38e-05	0.000256	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	1.37e-05	0.000255	CcSEcCtD
Lisinopril—Hypersensitivity—Valsartan—type 2 diabetes mellitus	1.37e-05	0.000255	CcSEcCtD
Lisinopril—Pain—Irbesartan—type 2 diabetes mellitus	1.37e-05	0.000254	CcSEcCtD
Lisinopril—Constipation—Irbesartan—type 2 diabetes mellitus	1.37e-05	0.000254	CcSEcCtD
Lisinopril—Insomnia—Losartan—type 2 diabetes mellitus	1.36e-05	0.000253	CcSEcCtD
Lisinopril—Hypersensitivity—Orlistat—type 2 diabetes mellitus	1.36e-05	0.000252	CcSEcCtD
Lisinopril—Paraesthesia—Losartan—type 2 diabetes mellitus	1.35e-05	0.000251	CcSEcCtD
Lisinopril—Urticaria—Metformin—type 2 diabetes mellitus	1.35e-05	0.00025	CcSEcCtD
Lisinopril—Chest pain—Ramipril—type 2 diabetes mellitus	1.35e-05	0.00025	CcSEcCtD
Lisinopril—Arthralgia—Ramipril—type 2 diabetes mellitus	1.35e-05	0.00025	CcSEcCtD
Lisinopril—Myalgia—Ramipril—type 2 diabetes mellitus	1.35e-05	0.00025	CcSEcCtD
Lisinopril—Dyspnoea—Losartan—type 2 diabetes mellitus	1.34e-05	0.00025	CcSEcCtD
Lisinopril—Anxiety—Ramipril—type 2 diabetes mellitus	1.34e-05	0.00025	CcSEcCtD
Lisinopril—Nausea—Glyburide—type 2 diabetes mellitus	1.34e-05	0.000249	CcSEcCtD
Lisinopril—Abdominal pain—Metformin—type 2 diabetes mellitus	1.34e-05	0.000249	CcSEcCtD
Lisinopril—Dizziness—Gliclazide—type 2 diabetes mellitus	1.34e-05	0.000249	CcSEcCtD
Lisinopril—Somnolence—Losartan—type 2 diabetes mellitus	1.34e-05	0.000249	CcSEcCtD
Lisinopril—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	1.34e-05	0.000249	CcSEcCtD
Lisinopril—Asthenia—Valsartan—type 2 diabetes mellitus	1.34e-05	0.000248	CcSEcCtD
Lisinopril—Discomfort—Ramipril—type 2 diabetes mellitus	1.33e-05	0.000247	CcSEcCtD
Lisinopril—Dyspepsia—Losartan—type 2 diabetes mellitus	1.33e-05	0.000246	CcSEcCtD
Lisinopril—Asthenia—Orlistat—type 2 diabetes mellitus	1.32e-05	0.000245	CcSEcCtD
Lisinopril—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	1.32e-05	0.000245	CcSEcCtD
Lisinopril—Pruritus—Valsartan—type 2 diabetes mellitus	1.32e-05	0.000245	CcSEcCtD
Lisinopril—Dry mouth—Ramipril—type 2 diabetes mellitus	1.32e-05	0.000245	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—HNF4A—type 2 diabetes mellitus	1.32e-05	0.000739	CbGpPWpGaD
Lisinopril—Decreased appetite—Losartan—type 2 diabetes mellitus	1.31e-05	0.000243	CcSEcCtD
Lisinopril—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	1.31e-05	0.000243	CcSEcCtD
Lisinopril—Confusional state—Ramipril—type 2 diabetes mellitus	1.3e-05	0.000242	CcSEcCtD
Lisinopril—Pruritus—Orlistat—type 2 diabetes mellitus	1.3e-05	0.000242	CcSEcCtD
Lisinopril—Fatigue—Losartan—type 2 diabetes mellitus	1.3e-05	0.000241	CcSEcCtD
Lisinopril—Anaphylactic shock—Ramipril—type 2 diabetes mellitus	1.29e-05	0.00024	CcSEcCtD
Lisinopril—Oedema—Ramipril—type 2 diabetes mellitus	1.29e-05	0.00024	CcSEcCtD
Lisinopril—Vomiting—Gliclazide—type 2 diabetes mellitus	1.29e-05	0.00024	CcSEcCtD
Lisinopril—Pain—Losartan—type 2 diabetes mellitus	1.29e-05	0.000239	CcSEcCtD
Lisinopril—Constipation—Losartan—type 2 diabetes mellitus	1.29e-05	0.000239	CcSEcCtD
Lisinopril—Rash—Gliclazide—type 2 diabetes mellitus	1.28e-05	0.000238	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	1.28e-05	0.000719	CbGpPWpGaD
Lisinopril—Dermatitis—Gliclazide—type 2 diabetes mellitus	1.28e-05	0.000237	CcSEcCtD
Lisinopril—Diarrhoea—Valsartan—type 2 diabetes mellitus	1.28e-05	0.000237	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—type 2 diabetes mellitus	1.27e-05	0.000716	CbGpPWpGaD
Lisinopril—Urticaria—Irbesartan—type 2 diabetes mellitus	1.27e-05	0.000236	CcSEcCtD
Lisinopril—Shock—Ramipril—type 2 diabetes mellitus	1.27e-05	0.000236	CcSEcCtD
Lisinopril—Headache—Gliclazide—type 2 diabetes mellitus	1.27e-05	0.000236	CcSEcCtD
Lisinopril—Abdominal pain—Irbesartan—type 2 diabetes mellitus	1.27e-05	0.000235	CcSEcCtD
Lisinopril—Body temperature increased—Irbesartan—type 2 diabetes mellitus	1.27e-05	0.000235	CcSEcCtD
Lisinopril—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	1.27e-05	0.000235	CcSEcCtD
Lisinopril—Tachycardia—Ramipril—type 2 diabetes mellitus	1.26e-05	0.000234	CcSEcCtD
Lisinopril—Diarrhoea—Orlistat—type 2 diabetes mellitus	1.26e-05	0.000234	CcSEcCtD
Lisinopril—Skin disorder—Ramipril—type 2 diabetes mellitus	1.26e-05	0.000233	CcSEcCtD
Lisinopril—Hyperhidrosis—Ramipril—type 2 diabetes mellitus	1.25e-05	0.000232	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—MMP1—type 2 diabetes mellitus	1.25e-05	0.000702	CbGpPWpGaD
Lisinopril—Feeling abnormal—Losartan—type 2 diabetes mellitus	1.24e-05	0.000231	CcSEcCtD
Lisinopril—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	1.23e-05	0.000229	CcSEcCtD
Lisinopril—Dizziness—Valsartan—type 2 diabetes mellitus	1.23e-05	0.000229	CcSEcCtD
Lisinopril—Anorexia—Ramipril—type 2 diabetes mellitus	1.23e-05	0.000229	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—AGT—type 2 diabetes mellitus	1.23e-05	0.000693	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	1.22e-05	0.000686	CbGpPWpGaD
Lisinopril—Dizziness—Orlistat—type 2 diabetes mellitus	1.22e-05	0.000226	CcSEcCtD
Lisinopril—Asthenia—Metformin—type 2 diabetes mellitus	1.22e-05	0.000226	CcSEcCtD
Lisinopril—Hypotension—Ramipril—type 2 diabetes mellitus	1.21e-05	0.000224	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—LEP—type 2 diabetes mellitus	1.21e-05	0.000679	CbGpPWpGaD
Lisinopril—Nausea—Gliclazide—type 2 diabetes mellitus	1.21e-05	0.000224	CcSEcCtD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—type 2 diabetes mellitus	1.2e-05	0.000677	CbGpPWpGaD
Lisinopril—Pruritus—Metformin—type 2 diabetes mellitus	1.2e-05	0.000223	CcSEcCtD
Lisinopril—Urticaria—Losartan—type 2 diabetes mellitus	1.2e-05	0.000222	CcSEcCtD
Lisinopril—Abdominal pain—Losartan—type 2 diabetes mellitus	1.19e-05	0.000221	CcSEcCtD
Lisinopril—Body temperature increased—Losartan—type 2 diabetes mellitus	1.19e-05	0.000221	CcSEcCtD
Lisinopril—SLC15A1—SLC-mediated transmembrane transport—ALB—type 2 diabetes mellitus	1.19e-05	0.000667	CbGpPWpGaD
Lisinopril—Vomiting—Valsartan—type 2 diabetes mellitus	1.19e-05	0.00022	CcSEcCtD
Lisinopril—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	1.18e-05	0.000219	CcSEcCtD
Lisinopril—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	1.18e-05	0.000219	CcSEcCtD
Lisinopril—Rash—Valsartan—type 2 diabetes mellitus	1.18e-05	0.000218	CcSEcCtD
Lisinopril—Dermatitis—Valsartan—type 2 diabetes mellitus	1.17e-05	0.000218	CcSEcCtD
Lisinopril—Vomiting—Orlistat—type 2 diabetes mellitus	1.17e-05	0.000217	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	1.17e-05	0.000658	CbGpPWpGaD
Lisinopril—Insomnia—Ramipril—type 2 diabetes mellitus	1.17e-05	0.000217	CcSEcCtD
Lisinopril—Headache—Valsartan—type 2 diabetes mellitus	1.17e-05	0.000217	CcSEcCtD
Lisinopril—Diarrhoea—Metformin—type 2 diabetes mellitus	1.16e-05	0.000216	CcSEcCtD
Lisinopril—Rash—Orlistat—type 2 diabetes mellitus	1.16e-05	0.000216	CcSEcCtD
Lisinopril—Paraesthesia—Ramipril—type 2 diabetes mellitus	1.16e-05	0.000216	CcSEcCtD
Lisinopril—Dermatitis—Orlistat—type 2 diabetes mellitus	1.16e-05	0.000215	CcSEcCtD
Lisinopril—Headache—Orlistat—type 2 diabetes mellitus	1.15e-05	0.000214	CcSEcCtD
Lisinopril—Dyspnoea—Ramipril—type 2 diabetes mellitus	1.15e-05	0.000214	CcSEcCtD
Lisinopril—Asthenia—Irbesartan—type 2 diabetes mellitus	1.15e-05	0.000213	CcSEcCtD
Lisinopril—Somnolence—Ramipril—type 2 diabetes mellitus	1.15e-05	0.000213	CcSEcCtD
Lisinopril—Dyspepsia—Ramipril—type 2 diabetes mellitus	1.14e-05	0.000211	CcSEcCtD
Lisinopril—Pruritus—Irbesartan—type 2 diabetes mellitus	1.13e-05	0.00021	CcSEcCtD
Lisinopril—Decreased appetite—Ramipril—type 2 diabetes mellitus	1.12e-05	0.000209	CcSEcCtD
Lisinopril—Dizziness—Metformin—type 2 diabetes mellitus	1.12e-05	0.000208	CcSEcCtD
Lisinopril—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	1.12e-05	0.000207	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CASP8—type 2 diabetes mellitus	1.12e-05	0.000628	CbGpPWpGaD
Lisinopril—Fatigue—Ramipril—type 2 diabetes mellitus	1.12e-05	0.000207	CcSEcCtD
Lisinopril—Hypersensitivity—Losartan—type 2 diabetes mellitus	1.11e-05	0.000206	CcSEcCtD
Lisinopril—Nausea—Valsartan—type 2 diabetes mellitus	1.11e-05	0.000206	CcSEcCtD
Lisinopril—Constipation—Ramipril—type 2 diabetes mellitus	1.11e-05	0.000205	CcSEcCtD
Lisinopril—Diarrhoea—Irbesartan—type 2 diabetes mellitus	1.1e-05	0.000204	CcSEcCtD
Lisinopril—Nausea—Orlistat—type 2 diabetes mellitus	1.09e-05	0.000203	CcSEcCtD
Lisinopril—Asthenia—Losartan—type 2 diabetes mellitus	1.08e-05	0.000201	CcSEcCtD
Lisinopril—Vomiting—Metformin—type 2 diabetes mellitus	1.08e-05	0.0002	CcSEcCtD
Lisinopril—Rash—Metformin—type 2 diabetes mellitus	1.07e-05	0.000199	CcSEcCtD
Lisinopril—Dermatitis—Metformin—type 2 diabetes mellitus	1.07e-05	0.000199	CcSEcCtD
Lisinopril—Pruritus—Losartan—type 2 diabetes mellitus	1.07e-05	0.000198	CcSEcCtD
Lisinopril—Feeling abnormal—Ramipril—type 2 diabetes mellitus	1.07e-05	0.000198	CcSEcCtD
Lisinopril—Headache—Metformin—type 2 diabetes mellitus	1.06e-05	0.000197	CcSEcCtD
Lisinopril—Dizziness—Irbesartan—type 2 diabetes mellitus	1.06e-05	0.000197	CcSEcCtD
Lisinopril—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	1.06e-05	0.000196	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—type 2 diabetes mellitus	1.04e-05	0.000584	CbGpPWpGaD
Lisinopril—Diarrhoea—Losartan—type 2 diabetes mellitus	1.03e-05	0.000192	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—INS—type 2 diabetes mellitus	1.03e-05	0.00058	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	1.03e-05	0.000579	CbGpPWpGaD
Lisinopril—Urticaria—Ramipril—type 2 diabetes mellitus	1.03e-05	0.000191	CcSEcCtD
Lisinopril—Abdominal pain—Ramipril—type 2 diabetes mellitus	1.02e-05	0.00019	CcSEcCtD
Lisinopril—Body temperature increased—Ramipril—type 2 diabetes mellitus	1.02e-05	0.00019	CcSEcCtD
Lisinopril—Vomiting—Irbesartan—type 2 diabetes mellitus	1.02e-05	0.000189	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—CCL2—type 2 diabetes mellitus	1.02e-05	0.000571	CbGpPWpGaD
Lisinopril—Rash—Irbesartan—type 2 diabetes mellitus	1.01e-05	0.000188	CcSEcCtD
Lisinopril—Dermatitis—Irbesartan—type 2 diabetes mellitus	1.01e-05	0.000187	CcSEcCtD
Lisinopril—Nausea—Metformin—type 2 diabetes mellitus	1.01e-05	0.000187	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	1.01e-05	0.000567	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	1e-05	0.000564	CbGpPWpGaD
Lisinopril—Headache—Irbesartan—type 2 diabetes mellitus	1e-05	0.000186	CcSEcCtD
Lisinopril—ACE—Metabolism of proteins—IGF1—type 2 diabetes mellitus	9.98e-06	0.000561	CbGpPWpGaD
Lisinopril—Dizziness—Losartan—type 2 diabetes mellitus	9.98e-06	0.000185	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	9.95e-06	0.000559	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	9.94e-06	0.000559	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	9.94e-06	0.000559	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	9.62e-06	0.000541	CbGpPWpGaD
Lisinopril—Vomiting—Losartan—type 2 diabetes mellitus	9.59e-06	0.000178	CcSEcCtD
Lisinopril—Hypersensitivity—Ramipril—type 2 diabetes mellitus	9.53e-06	0.000177	CcSEcCtD
Lisinopril—Nausea—Irbesartan—type 2 diabetes mellitus	9.52e-06	0.000177	CcSEcCtD
Lisinopril—Rash—Losartan—type 2 diabetes mellitus	9.51e-06	0.000176	CcSEcCtD
Lisinopril—Dermatitis—Losartan—type 2 diabetes mellitus	9.5e-06	0.000176	CcSEcCtD
Lisinopril—Headache—Losartan—type 2 diabetes mellitus	9.45e-06	0.000175	CcSEcCtD
Lisinopril—Asthenia—Ramipril—type 2 diabetes mellitus	9.28e-06	0.000172	CcSEcCtD
Lisinopril—Pruritus—Ramipril—type 2 diabetes mellitus	9.15e-06	0.00017	CcSEcCtD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—type 2 diabetes mellitus	9.12e-06	0.000512	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	9.09e-06	0.000511	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	8.99e-06	0.000505	CbGpPWpGaD
Lisinopril—Nausea—Losartan—type 2 diabetes mellitus	8.96e-06	0.000166	CcSEcCtD
Lisinopril—Diarrhoea—Ramipril—type 2 diabetes mellitus	8.85e-06	0.000164	CcSEcCtD
Lisinopril—Dizziness—Ramipril—type 2 diabetes mellitus	8.55e-06	0.000159	CcSEcCtD
Lisinopril—ABCB1—Allograft Rejection—CASP3—type 2 diabetes mellitus	8.45e-06	0.000475	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—type 2 diabetes mellitus	8.4e-06	0.000472	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SIRT1—type 2 diabetes mellitus	8.31e-06	0.000467	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—type 2 diabetes mellitus	8.28e-06	0.000465	CbGpPWpGaD
Lisinopril—Vomiting—Ramipril—type 2 diabetes mellitus	8.22e-06	0.000153	CcSEcCtD
Lisinopril—Rash—Ramipril—type 2 diabetes mellitus	8.16e-06	0.000151	CcSEcCtD
Lisinopril—Dermatitis—Ramipril—type 2 diabetes mellitus	8.15e-06	0.000151	CcSEcCtD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	8.11e-06	0.000456	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	8.1e-06	0.000455	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	8.1e-06	0.000455	CbGpPWpGaD
Lisinopril—Headache—Ramipril—type 2 diabetes mellitus	8.1e-06	0.00015	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	7.8e-06	0.000438	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	7.8e-06	0.000438	CbGpPWpGaD
Lisinopril—Nausea—Ramipril—type 2 diabetes mellitus	7.68e-06	0.000143	CcSEcCtD
Lisinopril—ABCB1—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	7.66e-06	0.000431	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	7.61e-06	0.000428	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—VEGFA—type 2 diabetes mellitus	7.17e-06	0.000403	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—type 2 diabetes mellitus	7.14e-06	0.000401	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	7.08e-06	0.000398	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	6.63e-06	0.000373	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—BHMT—type 2 diabetes mellitus	6.61e-06	0.000371	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TGFB1—type 2 diabetes mellitus	6.58e-06	0.00037	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	6.41e-06	0.00036	CbGpPWpGaD
Lisinopril—ABCB1—Allograft Rejection—TNF—type 2 diabetes mellitus	6.15e-06	0.000345	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	6.14e-06	0.000345	CbGpPWpGaD
Lisinopril—SLC15A1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	6.03e-06	0.000339	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AANAT—type 2 diabetes mellitus	5.78e-06	0.000325	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGDS—type 2 diabetes mellitus	5.78e-06	0.000325	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—type 2 diabetes mellitus	5.51e-06	0.00031	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPD2—type 2 diabetes mellitus	5.48e-06	0.000308	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CDO1—type 2 diabetes mellitus	5.48e-06	0.000308	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 2 diabetes mellitus	5.42e-06	0.000304	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	5.33e-06	0.0003	CbGpPWpGaD
Lisinopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—type 2 diabetes mellitus	5.28e-06	0.000297	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AK1—type 2 diabetes mellitus	5.22e-06	0.000294	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	5.09e-06	0.000286	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	5.09e-06	0.000286	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	4.97e-06	0.000279	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	4.94e-06	0.000278	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	4.91e-06	0.000276	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC5A4—type 2 diabetes mellitus	4.82e-06	0.000271	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MAT1A—type 2 diabetes mellitus	4.82e-06	0.000271	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—type 2 diabetes mellitus	4.73e-06	0.000266	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPP1R3C—type 2 diabetes mellitus	4.66e-06	0.000262	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ND1—type 2 diabetes mellitus	4.66e-06	0.000262	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—G6PC—type 2 diabetes mellitus	4.66e-06	0.000262	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ENPP1—type 2 diabetes mellitus	4.66e-06	0.000262	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HBA2—type 2 diabetes mellitus	4.66e-06	0.000262	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GCGR—type 2 diabetes mellitus	4.51e-06	0.000253	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—type 2 diabetes mellitus	4.49e-06	0.000252	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	4.33e-06	0.000243	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYTB—type 2 diabetes mellitus	4.26e-06	0.000239	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—OXCT1—type 2 diabetes mellitus	4.26e-06	0.000239	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 2 diabetes mellitus	4.17e-06	0.000234	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SRD5A1—type 2 diabetes mellitus	4.15e-06	0.000233	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	4.13e-06	0.000232	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD17B3—type 2 diabetes mellitus	3.96e-06	0.000223	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ACACA—type 2 diabetes mellitus	3.96e-06	0.000223	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—STAR—type 2 diabetes mellitus	3.96e-06	0.000223	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	3.96e-06	0.000222	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—type 2 diabetes mellitus	3.9e-06	0.000219	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ABCC8—type 2 diabetes mellitus	3.8e-06	0.000213	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CBS—type 2 diabetes mellitus	3.8e-06	0.000213	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC5A2—type 2 diabetes mellitus	3.65e-06	0.000205	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—COX2—type 2 diabetes mellitus	3.65e-06	0.000205	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—type 2 diabetes mellitus	3.63e-06	0.000204	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NCOA6—type 2 diabetes mellitus	3.59e-06	0.000202	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—type 2 diabetes mellitus	3.54e-06	0.000199	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD11B1—type 2 diabetes mellitus	3.53e-06	0.000198	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UCP2—type 2 diabetes mellitus	3.53e-06	0.000198	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—UCP3—type 2 diabetes mellitus	3.53e-06	0.000198	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	3.41e-06	0.000192	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	3.4e-06	0.000191	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	3.36e-06	0.000189	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PCK1—type 2 diabetes mellitus	3.32e-06	0.000186	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	3.25e-06	0.000183	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—type 2 diabetes mellitus	3.25e-06	0.000183	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 2 diabetes mellitus	3.18e-06	0.000179	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HK1—type 2 diabetes mellitus	3.11e-06	0.000175	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	3.04e-06	0.000171	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 2 diabetes mellitus	3.03e-06	0.00017	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GCKR—type 2 diabetes mellitus	3e-06	0.000169	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HSD3B2—type 2 diabetes mellitus	3e-06	0.000169	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—KCNJ11—type 2 diabetes mellitus	3e-06	0.000169	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPA—type 2 diabetes mellitus	3e-06	0.000169	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALDOB—type 2 diabetes mellitus	2.88e-06	0.000162	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	2.74e-06	0.000154	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GLP1R—type 2 diabetes mellitus	2.67e-06	0.00015	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	2.57e-06	0.000145	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A2—type 2 diabetes mellitus	2.5e-06	0.00014	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CPT1A—type 2 diabetes mellitus	2.45e-06	0.000137	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTR—type 2 diabetes mellitus	2.45e-06	0.000137	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NAMPT—type 2 diabetes mellitus	2.4e-06	0.000135	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GCK—type 2 diabetes mellitus	2.38e-06	0.000134	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HBA1—type 2 diabetes mellitus	2.38e-06	0.000134	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LIPC—type 2 diabetes mellitus	2.38e-06	0.000134	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP11A1—type 2 diabetes mellitus	2.37e-06	0.000133	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC9A1—type 2 diabetes mellitus	2.33e-06	0.000131	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CETP—type 2 diabetes mellitus	2.3e-06	0.000129	CbGpPWpGaD
Lisinopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—type 2 diabetes mellitus	2.26e-06	0.000127	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PSMD6—type 2 diabetes mellitus	2.14e-06	0.00012	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SREBF1—type 2 diabetes mellitus	2.14e-06	0.00012	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SNAP25—type 2 diabetes mellitus	2.14e-06	0.00012	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CTGF—type 2 diabetes mellitus	2.1e-06	0.000118	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMGCR—type 2 diabetes mellitus	2.08e-06	0.000117	CbGpPWpGaD
Lisinopril—ABCB1—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	2.04e-06	0.000115	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ADRA2A—type 2 diabetes mellitus	2.04e-06	0.000114	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP2E1—type 2 diabetes mellitus	1.96e-06	0.00011	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A1—type 2 diabetes mellitus	1.93e-06	0.000109	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP1A2—type 2 diabetes mellitus	1.93e-06	0.000109	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CYP3A4—type 2 diabetes mellitus	1.89e-06	0.000106	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GCG—type 2 diabetes mellitus	1.85e-06	0.000104	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—SLC2A4—type 2 diabetes mellitus	1.85e-06	0.000104	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.6e-06	8.98e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GNB3—type 2 diabetes mellitus	1.6e-06	8.98e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—HMOX1—type 2 diabetes mellitus	1.59e-06	8.94e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CAT—type 2 diabetes mellitus	1.57e-06	8.82e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOB—type 2 diabetes mellitus	1.52e-06	8.56e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GSTM1—type 2 diabetes mellitus	1.48e-06	8.33e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—LPL—type 2 diabetes mellitus	1.45e-06	8.18e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ADCY5—type 2 diabetes mellitus	1.42e-06	8e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—GPX1—type 2 diabetes mellitus	1.42e-06	7.98e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CD36—type 2 diabetes mellitus	1.38e-06	7.77e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPP2CA—type 2 diabetes mellitus	1.36e-06	7.67e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—MTHFR—type 2 diabetes mellitus	1.31e-06	7.36e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARA—type 2 diabetes mellitus	1.28e-06	7.22e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AGT—type 2 diabetes mellitus	1.24e-06	6.99e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—CALM1—type 2 diabetes mellitus	1.22e-06	6.88e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOE—type 2 diabetes mellitus	1.22e-06	6.85e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—APOA1—type 2 diabetes mellitus	1.21e-06	6.77e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PPARG—type 2 diabetes mellitus	1.06e-06	5.97e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—INS—type 2 diabetes mellitus	1.04e-06	5.85e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—ALB—type 2 diabetes mellitus	9.55e-07	5.37e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PIK3R1—type 2 diabetes mellitus	9.13e-07	5.13e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—NOS3—type 2 diabetes mellitus	9.13e-07	5.13e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—PTGS2—type 2 diabetes mellitus	8.35e-07	4.7e-05	CbGpPWpGaD
Lisinopril—ABCB1—Metabolism—AKT1—type 2 diabetes mellitus	4.2e-07	2.36e-05	CbGpPWpGaD
